Abeona Therapeutics (ABEO) Interest Expenses (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Interest Expenses of $1.4 million for Q1 2026, down 0.51% year-over-year from $1.4 million in Q1 2025, and up 173.11% quarter-over-quarter from -$1.9 million in Q4 2025.
Abeona Therapeutics (ABEO) Interest Expenses (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Expenses history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 0.51% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 0.51% YoY), while the FY2025 annual figure was $74.9 million, up 1680.47% from the prior year.
- Interest Expenses for Q1 2026 stood at $1.4 million, up from -$1.9 million in the prior quarter.
- The five-year high for Interest Expenses was $11.5 million in Q1 2022, with the low at -$1.9 million in Q4 2025.
- The 5-year median for Interest Expenses is $1.4 million (2023), against an average of $2.9 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses surged 892.66% in 2024, then sank 271.53% in 2025.
- Abeona Therapeutics' Interest Expenses stood at $178000.0 in 2022, then tumbled by 38.76% to $109000.0 in 2023, then soared by 892.66% to $1.1 million in 2024, then tumbled by 271.53% to -$1.9 million in 2025, then jumped by 173.11% to $1.4 million in 2026.
- Business Quant data shows ABEO's Interest Expenses at $1.4 million in Q1 2026, -$1.9 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Dec 31, 2025 | -1.86 Mn |
| Dec 31, 2025 | -1.86 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 5.42 Mn |
| Sep 30, 2024 | 5.42 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |